GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price ...
GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China. The London-based pharmaceutical company said the China Medical Products ...
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...
UK pharma major GSK late Friday announced that the US Food and Drug Administration (FDA) has approved Penmenvy (meningococcal ...
After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...
Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...
City brokers expect dividends on GSK shares will keep marching higher. Is the FTSE 100 share a top passive income stock to ...
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
GSK PLC on Saturday said the US Food & Drug Administration has approved its vaccine against five common disease-causing serogroups of Neisseria meningitidis. The FDA approved Penmenvy for use in ...
Activist investors take stakes in what they see as underperforming companies in order to agitate for change, which they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results